Core for Life - a new European alliance in biomedical research: http://t.co/Hvv6P88kRt
posted
FlandersBio informs you about important regional and national life sciences news. Send us your news. If your news is of interest to the life sciences community, we will post it on our website.
Amakem NV, a clinical stage ophthalmology company, will present new pre-clinical data on its lead drug candidate, the locally-acting Rho kinase (ROCK) inhibitor AMA0076, as well as data on a novel kinase inhibitor at the 2013 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting being held in Seattle, WA on May 5-9, 2013. The ARVO meeting is the world’s largest gathering of international eye and vision researchers. read more
ThromboGenics NV (Euronext Brussels: THR), an integrated biopharmaceutical company focused on developing and commercializing innovative ophthalmic medicines, today announces that its partner Alcon has launched JETREA® in Germany, the second European market where the product is now available. read more
